DiscoverThe Brain PodcastAnti-IgLon5 disease risk is mediated by HLA-DQB1*05 subtypes: when neuroimmunology meets neurodegeneration
Anti-IgLon5 disease risk is mediated by HLA-DQB1*05 subtypes: when neuroimmunology meets neurodegeneration

Anti-IgLon5 disease risk is mediated by HLA-DQB1*05 subtypes: when neuroimmunology meets neurodegeneration

Update: 2024-08-14
Share

Description

Welcome to the 21th episode of The Brain Podcast - the official podcast of the journals Brain and Brain Communications

This episode features a discussion with the first author Dr Selina Yogeshwar of the Brain article entitled: HLA-DQB1*05 subtypes and not DRB1*10:01 mediates risk in anti-IgLON5 disease 

Dr Yogeshwar offers exciting insight into the genetic mechanisms of a relatively recently discovered disease anti-IgLON5. She also discusses foundational information into how neuroimmunology, neurogenetics and neurodegeneration intersect in this fascinating condition. This exciting episode is not to be missed! 

Check out the full article on the Brain website: https://doi.org/10.1093/brain/awae048

This episode was co-hosted by Adam Handel and Chaitra Sathyaprakash,  edited and produced by Chaitra and Xin You Tai, co-produced by Antonia Johnston, original music by Ammar Al-Chalabi.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Anti-IgLon5 disease risk is mediated by HLA-DQB1*05 subtypes: when neuroimmunology meets neurodegeneration

Anti-IgLon5 disease risk is mediated by HLA-DQB1*05 subtypes: when neuroimmunology meets neurodegeneration